MED3000 Gel for Post-Prostatectomy Erectile Dysfunction

Recruiting in Palo Alto (17 mi)

Overseen byMartin Kathrins, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Brigham and Women's Hospital

No Placebo Group

Trial Summary

What is the purpose of this trial?The investigators are doing this research to evaluate the efficacy and safety of topical MED3000 therapy in men with persistent erectile dysfunction 1.5 to 4 years following radical prostatectomy surgery.

Eligibility Criteria

Men aged 40-70 who've had nerve-sparing prostate surgery for low/intermediate-risk cancer 1.5-4 years ago, with ongoing erectile dysfunction despite treatments, in a stable relationship, and no disease recurrence. Excludes those with genital abnormalities or complications from surgery that could affect treatment.

Inclusion Criteria

Subjects have any degree of erectile dysfunction based on IIEF questionnaire

I am between 40 and 70 years old.

I had prostate surgery between 1.5 and 4 years ago.

+2 more

Exclusion Criteria

I have previously received hormone therapy for cancer.

I have had or am scheduled for radiation therapy in the pelvic area and/or hormone therapy.

Any other condition that would prevent the patient from completing the study, as judged by the Principal Investigator

+4 more

Participant Groups

The trial is testing MED3000 topical gel's effectiveness and safety on men experiencing erectile dysfunction after radical prostatectomy (prostate removal). It aims to see if this gel can help improve sexual function when used as needed before sexual activity.

1Treatment groups

Experimental Treatment

Group I: MED3000 topical gel treatmentExperimental Treatment1 Intervention

All qualified enrolled patients will receive treatment with MED3000 topical gel on demand through the 12-week follow-up visits.